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ABSTRACT:

Cryptosporidium

par v um, a protozoan

parasite

infecting

epithelial cells lining the intestinal tract of animals and humans, causes
fulminate diarrhea and malabsorption
damage to the cellular brush border.

of essential nutrients

following

The present study was undertaken

evaluate the use of a pentose sugar (D-xylose) in a standardized
as an indicator of malabsorption
dexamethasone

due to cryptosporidiosis

(DEX)-immunosuppressed

to

tolerance test

in the

adult C57BL/6N mouse model.

One group containing 14 experimental mice (in addition to appropriate
control groups) was immunosuppressed
injections of DEX (125 µg/mouse).

On day 7 postimmunosuppression,

were inoculated orally with 104 C. parvum
month postinoculation,

using daily intraperitoneal

oocysts/mouse.

feces from individual

mice

Approximately

mice were checked for oocyst

1
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shedding using an indirect immunofluorescent

assay to confirm patent

infections. After 24 hours of fasting, infected mice were administered Dxylose (2.5 mg/ g body weight) by gavage. Mice were killed at either 45 or 90
minutes post-D-xylose administration, blood was collected from the chest
cavity, and the serum was harvested.

Sections of the proximal duodenum

and distal ileum of each mouse were histologically prepared for quantitation
of C. parvum using brightfield microscopy.
spectrophotometer

Serum was analyzed with a

(520 nm) by employing a calorimetric reaction as a

measure of the absorptive capacity of D-xylose in the small intestine of C.
parvum-infected

mice. Statistical analysis revealed no significant correlation

between the number of parasites present and intestinal absorption of Dxylose. However, administration of DEX was positively correlated to D-xylose
absorption.
inappropriate

These findings indicate that the xylose tolerance test is
in the adult C57BL/6N mouse model for evaluating

malabsorption due to cryptosporidiosis in the presence of DEX.
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INTRODUCTION

Cryptosporidium parvum is a widespread
cause diarrhea in humans and animals.

protozoan

parasite shown to

A common route of infection is

through fecal-oral means (17). Diarrhea ranges from moderately severe in
immunocompetent

individuals

immunocompromised

to a life threatening,

cholera-like illness in

individuals . This parasite has recently received

greater attention due to its impact on patients with acquired
immunodeficiency

syndrome.

C. parvum commonly manifests itself with

clinical symptoms of fever associated with abdominal pain and chronic
diarrhea causing weight loss (3).
immunocompromised

The differences between

host and immunocompetent

host reactions to C.

parvum infection suggest that significant differences exist between intestinal
tract responsiveness

of the two groups.

Currently there are no effective treatments
and consequently

for C. parvum infection

an accelerated effort is underway to develop methods of

studying the organism.

Improved understanding

help develop effective treatments
methods of investigating

of C. parvum will certainly

in the near future.

biological properties of this organism in our

laboratory at Utah State University will undoubtedly
effective treatment.
gastrointestinal
of the disease.

In vitro and in vivo

An effective chemotherapy

contribute towards an

directed towards

tract treatment could offer hope of preventing

magnification
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Infection has been observed in several regions of the intestinal tract in
different species but it is most commonly found in the distal intestine and in
the colon. The detrimental effects of this infection on the villi of the
intestine have been well documented (5, 12). Such effects as intestinal
dysfunction, villous atrophy and crypt hypertrophy have been noted. These
effects have also been related to decreased absorption of nutrients by intestinal
cells (11). An effective agent to study malabsorption will aid further studies of
the effects of this parasite by revealing nutrient deficiencies that may be
interfering .
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LITERATURE REVIEW
History

In 1912, E. E. Tyzzer identified Cryptosporidium parvum as a
protozoan parasite in the phylum Apicomplexa, class Sporozoasida, order
Eucoccidiorida, and family Cryptosporidiidae(18).
initial identification,

For many years after the

little research was done on C. parvum until it was

identified as a possible cattle pathogen (14). This led to increased interest in
studies of this parasite.

Recently, more interest has developed due to

increased number of immunodeficient

humans such as those with AIDS. An

infection with C. parvum in these individuals
life-threatening

is very detrimental

and often

.

Life cycle

Cryptosporidium parvum is a small (2-S)um depending

on stage in life

cycle) coccidian parasite that, for the most part, infects the respiratory tree, the
gastrointestinal
watery diarrhea,

tract, and associated organs (8). Infection can be identified by
emaciation, and intestinal villous atrophy (8, 10, 12). The

infective stage of its life is the thick-walled oocyst produced from fertilization
of the macrogamete

(an equivalent of an ovum) by the microgamete

(the

equivalent of sperm) (8). The life cycle is illustrated in Figure 1. The mode of
transmission is typically through food and/ or water contaminated by feces of
an infected host . Once the oocysts are ingested, they develop into the
sporozoite which develops into the trophozoite that infects a new host's
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epithelial cells. This develops into a Type I meront which either continues
through the cycle and develops into a Type II meront or returns to infect a
different epithelial cell in the host. The infection of a host cell requires that
the sporozoites excyst from the oocyst and attach to the intestinal villi. The
host cell membrane then encapsulates the sporozoite and thin membranes
envelop the parasite.

The encapsulation process of the oocysts can lead to

decreased microvillar disaccharidases

and forms vacuoles containing clear

fluid . This is thought to cause damage to the absorptive capacities of the villi
(4, 13).

Though many agents have been tested as possible treatments, as of yet,
there is no known effective chemotherapeutic

treatment for

cryptospori dio sis.
Analysis of Malabsorption

A nutrient absorption analysis can be used to analyze damage in the
intestinal tract of an individual.

Several agents, such as fat and vitamin A,

are commonly used to test malabsorption

(6, 7, 19). To ensure proper analysis,

it is necessary to use agents which can be easily identified (16). This can be
done by either radiologically labeling the test agent or by using one that is not
commonly found in the system.

Both methods have been used but their

reliability can be influenced by physiological variations of the patient .
Specifically, the absorption site can vary greatly depending on the species (9).
This differentiation

can be due to such things as the individual environment

and the particular diet of the test organism.
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A common analysis of malabsorption

can be done by employing a

calorimetric reaction. The method was first detailed by Roe and Rice (15).
Simply, this method utilizes deproteinizing

reagents added to the serum

sample to reduce interfering proteins and a colorizing reagent (p bromoanaline)

to produces a color when heated to 70 ° C for ten minutes.

Following the color conversion, the sample is then placed in a
spectrophotometer

at 520 nm and the absorption is read.

Cryptosporidium parvum commonly infects the small intestine and
can disrupt the nutrient absorption of its host (5). As was mentioned
previously, disruption can occur from the damage caused to the villi through
the infection process.

Presently, malabsorption

of carbohydrates

intestine infected with C. parvum is not well understood.

from mouse
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OBJECTIVES AND HYPOTHESES
The uncertainties

of malabsorption

previously mentioned have led to

the following objectives and hypotheses for this study .
Objective 1: Determine any correlation between infection of the villi and
decreased absorption of nutrients.
Hypothesis 1: Infection of the brush border of the small intestine leads to
damage of absorptive capacities of cells, which causes nutrient contents to be
greater in feces than in the blood .
Objective 2: Evaluate the potential of D-xylose, an easily monitored
carbohydrate

not commonly found in blood, to measure intestinal absorption

alterations caused by C. parvum infection.
Hypothesis 2: A readily detected monosaccharide,

such as D-xylose, will

reveal that its serum blood levels are measurably lowered in infected mice.
Objective 3: Monitor the effects of dexamethasone,

an immunosuppressant,

on absorptive alterations caused by C. parvum.
Hypothesis 3: The effects of dexamethasone,

a glucocorticosteriod,

will not

significantly alter absorption of D-xylose in C. parvum infected mice.
Objective 4: Develop an effective diagnostic, if possible, to detect C. parvum
affected malabsorption

and therefore reduce production losses.

Hypothesis 4: Early C.parvum infection of the small intestine alters
absorption and can be monitored by monosaccharide

administration.
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MATERIALS AND METHODS
Oocysts used in this investigation were generated by infecting a one day
old Holstein calf using procedures outlined by Yang and Healey (21). The
feces were mixed with 5% potassium dichromate solution and stored at 4 °C.
Fecal collections were strained and oocysts purified using discontinuous
sucrose gradient centrifugation

(2). Briefly, the process of discontinuous

sucrose gradients involves two contrasting sugar solutions:
water/sucrose

and a 2:1 water/sucrose.

a 4:1

Sugar solutions were layered in a

centrifuge tube and 20 ml of strained feces were overlaid and centrifuged at
1500 x g for 25 minutes.
two sucrose solutions.

Oocysts were recovered from the interface layer of the
Collections were saline-washed and resuspended

2.5% potassium dichromate.

in

This process wa s repeated to purify the oocysts,

and the final collection was suspended in 2.5% potassium dichromate and
refrigerated at 4°C.
Female C57BL/ 6N mice approximately six to eight weeks of age were
purchased from Taconic Inc. and housed in the Laboratory Animal Research
Center at Utah State University.

Mice were housed in plastic cages (5

mice/ cage) with wire tops and received food and water ad libitum.
Mice were randomly assigned to one of the following treatment groups
(Figure 1.): 1) Non-immunosuppressed,

non-infected, given D-xylose

2) Immunosuppressed,

non-infected, given D-xylose

3) Immunosuppressed,

infected, given D-xylose

4) Immunosuppressed,

infected, not given D-xylose .
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#mice /group I

Group 1

All test mice
mice contained
in cages at the

p

No DEX, No infection, given D-xylose

10

I

5

I

14

I

7

I

Group2
,; given DEX, No infection, given D-xylose

~

LARC

Group3

given DEX, infected , given D-xylose

Group 4
given DEX, infected, no D-xylose

Figure 1. Identification of four test groups of mice randomly assigned
dexamethasone,

C. parvum infection and D-xylose administration

the number of mice per group. Mice were immunosuppressed

including

and infected

but were not given D-xylose until the day of the digestion experiment.

Purified oocysts were prepared for mouse infection by washing once in
bleach, twice in sterilized Hank's balanced saline solution, and once with
sterile RPMI 1640 (Sigma Chem. Co.) to remove the potassium dichromate.
Seven days postimmunosuppression,
intragastric administration

mice were infected with C. parvum by

of 104 oocysts/mouse,

using a 22-gauge straight

feeding needle.
D-xylose administration.

administration,

Twelve hours prior to D-xylose

mice were fasted to prevent foodstuffs from interfering in the
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trial. To determine D-xylose quantities

to be administered, mice were

weighed 24 hr prior to the digestion experiment.

The calculated dosage was

25 mg D-xylose per gram body weight. D-xylose samples were prepared in
advance and appropriate dosage for each individual mouse placed in a
prelabeled 2 ml microcentrifuge

tube and administered

to each animal using

a 22 gauge feeding needle when the trial was initiated.
Sacrificing mice and sample collection.

Immediately prior to

sacrificing, mice were removed from their cages and held briefly in a laminar
flow hood to allow collection of feces. Collections were placed in labeled 2 ml
microcentrifuge

tubes and suspended in potassium dichromate.

feces were stored at 4° C until Immunoflourescent

Collected

assay (IFA) could be

completed.
Mice were sacrificed in two divisions to allow a more accurate analysis
since the D-xylose absorption curve had not been completely determined at
this time. Randomly selected mice from each group were sacrificed at either
45 or 90 minutes postadministration.

Blood was immediately extracted from

the chest cavity and placed into 2 ml microcentrifuge tubes, labeled, and
allowed to clot. The entire gastrointestinal tract was harvested and placed in
15 ml of 10% formalin in a 50 ml conical centrifuge tube.
Processing blood samples.

Microcentrifuge tubes containing clotted

blood were centrifuged at 1000 x g for 5 min. The serum was collected and
placed in a new microcentrifuge tube and stored at 0° C. Analysis of serum
samples was carried out according to the procedure outlined by Dahlqvist (7)

15

with some modifications to adjust for reduced sample quantity.

The analysis

procedure began with 10µ1 serum samples being pipetted into 70 µl of water
plus 10µ1 of barium hydroxide and 10µ1 of zinc sulfate . This was centrifuged
at 1000 x g for 5 min. Sixty microliters of the supernatant were placed into
duplicate tubes and 300 µl of para-bromoanaline

(Sigma Chem. Co.) added .

One of the duplicate tubes was placed in a 70°C water bath for 10 min and the
othe r was set aside and utilized as a spectroscopy blank. The heated tube was
removed from the water bath and all tubes were placed in darkness at room
temperature

for 70 minutes.

spectrophotometrically

D-xylose concentration was

measured at 520 nm . The absorption was measured

using the unheated tube as a blank and calibrating the spectrophotometer
each sample.

for

Tubes were read within 30 min of removal from darkness . A

calculation of absorbance of the sample to absorbance of a standard D-xylose
preparation was performed on the results to determine the blood D-xylose
concentration .
Fecal analysis.

Fecal collections were analyzed for oocyst concentration

using the IFA staining technique (1). This was achieved by first using an
inoculating loop to apply smears on glass slides approximately
diameter.

one inch in

Smears were allowed to dry for 30 min and were then flame fixed.

Smears were treated with 80 µl of anti-oocyst IgM and incubated at 37° C for 30
min. Slides were washed three times using phosphate buffered saline (PBS).
The second antibody, a fluorescent labeled anti-mouse IgM, was applied at 80

16

µl per slide. Slides were again incubated at 37° C for 30 minutes and washed
three times with PBS. Two drops of glycerol/PBS were applied and cover
slips were placed on the slides and preparations were examined using an
ultraviolet light microscope (Carl Zeiss, Germany) with a 40x objective. The
oocysts were quantified with a single pass through the center of the smear.
Histological examination of tissues.

Two regions of the small intestine

were examined, the terminal ileum and proximal duodenum . The regions
were approximately

1 cm in length and embedded in paraffin.

Thin (4µm)

sections of the tissues were stained with hematoxylin and eosin . The
prepared slide was read using a light microscope with a l00x oil immersion
objective. Infection was noted by the colonization of the villi with small
(4µm in diameter) spherical oocysts attached to the lumenal side of the villi

or located within the crypts. The level of infection was calculated using ten
random countings of oocysts in the villi. Countings were made from the
apex of one villous to the apex of an adjacent villous .
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RESULTS AND DISCUSSION
Fecal analysis.

Mouse fecal collections were examined using the IFA

technique to determine parasites intensity in each of the four treatment
groups.

Significant differences existed between fecal oocyst concentrations of

treated and control mice (Figure 2). Groups 3 and 4 had well established
infections, while groups 1 and 2 remained uninfected or showed little
infection.
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Figure 2. Number of oocysts per ocular field using the IFA technique to
analyze a sample fecal smear.
Histological examination of tissues.

The site of greatest colonization

by the parasite is typically the terminal regions of the small intestine.

The

histological examination confirmed that there were highly significant
differences between the colonization of the terminal ileum and the proximal
duodenum

(Figure 3). There was also significant swelling of the villi which

resulted in a loss of the finger-like morphology.

The terminal ileum of
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infected groups had an average oocysts per villi ratio of 40 (Figure 3).
Differences among the infected groups were also seen in the significant
variation in infection intensities noted in the graph.
45
40
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OOCYST/ILEUM

Iii

AVG.

OOCYST/DUODENUM

FOUR

SECTION
SECTION

Figure 3. Cryptosporidium parvum colonization in the proximal duodenum
and the terminal ileum. Note the overwhelming differences in infection
rates.
D-xylose analysis . Positive absorption of D-xylose was correlated with

the specific treatment groups given D-xylose (Figure 4). There was no
significant difference of D-xylose absorbed between the 45 and 90 minute
collection groups. The control groups of this experiment returned expected
low values for D-xylose absorption.
Within the 45-minute collection group, there was a significantly higher
amount of D-xylose absorbed from the immunosuppressed

non-infected
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group two than the non-immunosuppressed,

non-infected

control group one

(Figure. 4). The greatest observed amount absorbed occurred in the
immunosuppressed,

infected group 3.

Relatively similar trends were noted in the 90-minute collection group .
There was, however, a significant difference seen in the immunosuppresed,
non infected group . It had an eighteen percent lower absorption value than
the control group and a thirty-seven percent lower absorption value than the
infected group . This can be explained by the maximum absorption times for
D-xylose in the mouse. After the administration

of D-xylose there is a peak of

D-xylose absorbed into the blood at approximately

60 minutes, the absorption

then rapidly drops off over the next 60 minutes(20).
There is also a noted variation between the nonimmunosuppressed,
noninfected groups at both 45 and 90 minutes and the immunosuppressed
infected groups . The immunosuppressed
higher then nonimmunosuppressed

groups were an average 11 percent

groups. The individual

groups along

with the number in each group, the time of sampling and the type of
treatment administered

are shown in Table 1.

0.40
Q)

g 0.30
C'CS
..Cl
....
0

(/)

..o 0.20
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4NNY 4YNY 4YYY 4YYN 9NNY 9YNY 9YYY 9YYN
Group

one

two

three

four

one

two

three
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1------------------45 minu tes------------1 1--------------90 minutes---------------- I

Figure 4. Comparison
treatment

of the D-xylose absorbance among the different

groups.

Table 1. Details the separate groups including the number of mice in each
group, the time of sampling and the individual

treatments

given or not

given.
Number

Min. for Sampling

lmSup

Infection

Xylose

4NNY

4

45

No

No

Yes

4YNY

2

45

Yes

No

Yes

4YYY

7

45

Yes

Yes

Yes

4YYN

4

45

Yes

Yes

No

9NNY

6

90

No

No

Yes

9YNY

3

90

Yes

No

Yes

9YYY

7

90

Yes

Yes

Yes

9YYN

3

90

Yes

Yes

No
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A repeat analysis was performed on the original serum samples using
the same procedures and the results are shown in Figure 5. There were the
same trends noted in the original examination though the absorption
amounts were lower (average absorption value lower by 13%).
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Group
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Figure 5. Additional

comparison of the differences among the groups in the

absorption of D-xylose. Note that the same trends are seen in the repeat
analysis as were originally noted and the overall lower absorption

percentage.
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SUMMARY AND CONCLUSIONS
Both the fecal and the histological examinations gave positive results
for infection.
occurred.

In all mice that had been infected, a significant colonization had

Histological preparations

exhibited definitive damage to the

epithelial tissues including villous atrophy and hyperplasia.
examinations

it follows that previously documented

From these

malabsorption

should

have been measured in the tissues, provided the proper malabsorption

test

agent was used (5, 11, 12, 16).
D-xylose analysis.

Data analysis revealed that no correlation existed

between C. parvum infection and intestinal D-xylose absorption. There were
subtle differences between 45 and 90-minute collection groups, although an
absorption curve for humans exists in the literature which indicates that Dxylose absorption should be similar during these time periods .
Further analysis revealed that there was a positive correlation between
DEX administration

and intestinal D-xylose absorption.

Results conflicted

with our original hypothesis that DEX would not have interfering effects on
the test. The effects of a glucocorticoid on the positive absorption of D-xylose
from the intestine is great enough that its appearance masks the effects of
cryptopsoridiosis

on D-xylose absorption.

In agreement with published texts, there were differences in the site of
absorption, depending on the species . In the mouse there is a greater D-xylose
absorption in the proximal areas and this absorption decreased further down
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the intestinal tract (9, 20). Since there was a greater infection in distal then
proximal intestinal sections, there is a high probability that the absorption
analysis of an agent absorbed from proximal region of the intestine would be
altered. This explanation, in conjunction with the effects of DEX, provides
some understanding

for the absorption increase of D-xylose in infected

compared to noninfected individuals.
differences are not fully understood
Conclusions

The exact reasons for absorption site
at this time.

. This experiment demonstrated

a good determinant

to evaluate altered absorption in the adult C57BL/6N

mouse model due to cryptosporidiosis.
conjunction with physiological
the malabsorption
immunosuppressive

that D-xylos e absorption is not

The interfering affects of DEX, in

differences in the mouse model, confound

results when D-xylose is used. The effects of the
agent DEX on the absorption of the pentose nutrient can

be of assistance to future experiments . Increased absorption of D-xylose in
subjects receiving DEX can explain the increased weight gain in mice
immunosuppresed

for some time and future tests examining the health of

the patient need to take this into consideration.
For further malabsorption
the following reagents;

studies, results of this experiment suggest

1) Sucrose, because it has been shown greater

amounts absorbed in the distal intestine sections than in proximal sections,
therfore it would better detail any loss of absorptive capacity due to C. parvum
infection and/ or 2) Lipid, due to its absorption into fecal materials which
would eliminate the variation caused by a glucocorticoid on absorption into
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blood. It is also be suggested that further studies be completed on the
physiological mechanisms of the mouse model before conclusions about C.
parvum induced

malabsorption

can be reached .
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